Loading...
Loading...
Pharmaceutical Importer · #11 buyer for Etoposide · $180.4K import value · 9 shipments · MALAYSIA · DGFT Verified
Fresenius Kabi Malaysia SDN BHD is the #11 importer of Etoposide from India with $180.4K in import value and 9 verified shipments. Fresenius Kabi Malaysia SDN BHD holds a 1.7% market share in Etoposide imports based in MALAYSIA. Overall, Fresenius Kabi Malaysia SDN BHD imports 8 pharmaceutical products worth $3.5M across 2 therapeutic categories.

| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| INTAS PHARMACEUTICALS LIMITED | $4.8M | 580 | 11 |
| FRESENIUS KABI ONCOLOGY LIMITED | $1.9M | 126 | 20 |
| VENUS REMEDIES LIMITED | $988.8K | 139 | 20 |
| MYLAN LABORATORIES LIMITED | $350.0K | 7 | 2 |
| HETERO LABS LIMITED | $300.0K | 6 | 2 |
| INTAS PHARMACEUTICALS LTD | $294.6K | 16 | 6 |
| MEDORBIS TRADE LLP | $200.0K | 4 | 2 |
| GETWELL PHARMACEUTICALS | $136.2K | 35 | 9 |
| NV REMEDIES PRIVATE LIMITED | $132.6K | 5 | 3 |
| KHANDELWAL LABORATORIES PRIVATE LIMITED | $98.1K | 14 | 5 |
India's top Etoposide suppliers include INTAS PHARMACEUTICALS LIMITED, FRESENIUS KABI ONCOLOGY LIMITED, VENUS REMEDIES LIMITED. These companies represent the primary source of Etoposide exports from India, serving buyers like Fresenius Kabi Malaysia SDN BHD in MALAYSIA and other global markets.
Buyers ranked immediately above and below #11 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 9 | ALLOGA FRANCE | NETHERLANDS | $235.4K | 23 | $10.2K |
| 10 | ACCORD UK | UNITED KINGDOM | $235.3K | 15 | $15.7K |
| 11 | FRESENIUS KABI MALAYSIA SDN BHD ★ | MALAYSIA | $180.4K | 9 | $20.0K |
| 12 | M/S OQCORP S.A.C. | PERU | $164.0K | 7 | $23.4K |
India exported $4.7M worth of Etoposide through 2,129 shipments from 237 suppliers to 122 countries, serving 598 buyers globally. Fresenius Kabi Malaysia SDN BHD imports $180.4K of this total, accounting for 1.7% of India's Etoposide exports with 9 shipments from MALAYSIA.
Fresenius Kabi Malaysia SDN BHD's average Etoposide order value is $20.0K per consignment, based on 9 shipments totaling $180.4K. Fresenius Kabi Malaysia SDN BHD is based in MALAYSIA and ranks #11 among all Etoposide importers from India by value.
Top Indian Etoposide suppliers include INTAS PHARMACEUTICALS LIMITED ($4.8M), FRESENIUS KABI ONCOLOGY LIMITED ($1.9M), VENUS REMEDIES LIMITED ($988.8K), MYLAN LABORATORIES LIMITED ($350.0K), HETERO LABS LIMITED ($300.0K). These companies represent the primary source of Etoposide exports from India.
Fresenius Kabi Malaysia SDN BHD ranks #11 among 598 Etoposide importers from India with a 1.7% market share. The top 3 importers are EVERSANA LIFE SCIENCES SERVICES,LLC ($1.5M), FRESENIUS KABI DEUTSCHLAND GMBH ($475.0K), AMERISOURCE HEALTH SERVICES ($350.0K). Fresenius Kabi Malaysia SDN BHD processed 9 shipments from MALAYSIA.
Fresenius Kabi Malaysia SDN BHD also imports these oncology products. Each links to the detailed product page.
Fresenius Kabi Malaysia SDN BHD imports 8 products worth $3.5M. Beyond Etoposide, top products include Carboplatin, Oxaliplatin, Docetaxel, Epirubicin, Gemcitabine. View the complete Fresenius Kabi Malaysia SDN BHD profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Etoposide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for Fresenius Kabi Malaysia SDN BHD's Etoposide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Fresenius Kabi Malaysia SDN BHD
Full Company Profile →
8 products · $3.5M total trade · 2 categories
| 6 | ROPSOHN THERAPEUTICS SAS | COLOMBIA | $150.0K | 3 | $50.0K |
Fresenius Kabi Malaysia SDN BHD ranks #11 among 598 Etoposide importers from India. Average shipment value of $20.0K compared to the market average of $7.8K. The closest competitors by value are ALLOGA FRANCE and ACCORD UK.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 122+ countries, 598+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, supplier contacts, and formulation details for Fresenius Kabi Malaysia SDN BHD.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Etoposide. For current order-level data, contact TransData Nexus.